KYRNF vs MRK: Which Stock is Better?
Side-by-side comparison of KYORIN Pharmaceutical Co., Ltd. and Merck & Co Inc in 2026
KYRNF
KYORIN Pharmaceutical Co., Ltd.
$10.31
MRK
Merck & Co Inc
$119.07
Key Metrics Comparison
| Metric | KYRNF | MRK | Winner |
|---|---|---|---|
| Market Cap | $592.33M | $294.39B | MRK |
| P/E Ratio | 10.11 | 16.36 | KYRNF |
| EPS (TTM) | $1.02 | $7.28 | MRK |
| Revenue Growth | -0.0% | 0.1% | MRK |
| Gross Margin | 45.3% | 77.2% | MRK |
Analyze KYRNF
Full quant analysis
Analyze MRK
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KYRNF or MRK a better investment?
Comparing KYRNF and MRK: KYORIN Pharmaceutical Co., Ltd. has a market cap of $592.33M while Merck & Co Inc has $294.39B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KYRNF and MRK?
KYRNF (KYORIN Pharmaceutical Co., Ltd.) and MRK (Merck & Co Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KYRNF or MRK?
Based on P/E ratios, KYRNF trades at a lower multiple (10.1x vs 16.4x).
Which is growing faster: KYRNF or MRK?
MRK has higher revenue growth at 0.1% vs -0.0% for KYRNF.
Which company is more profitable: KYRNF or MRK?
Merck & Co Inc (MRK) has higher gross margins at 77.2% compared to 45.3% for KYRNF.
Which is the larger company: KYRNF or MRK?
Merck & Co Inc (MRK) is larger with a market cap of $294.39B compared to $592.33M for KYRNF.
Should I buy KYRNF or MRK in 2026?
Both KYRNF and MRK have investment merit. KYRNF trades at $10.31 while MRK trades at $119.07. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KYRNF and MRK stock?
Key differences: Market Cap ($592.33M vs $294.39B), P/E Ratio (10.1x vs 16.4x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (45.3% vs 77.2%).